tbuckley/cabot-search huggingface dataset:
Erratum
Authors: A Anderson, J Aberorombie, Mrs Anderson, P Abercrombie, A Baker, London Barker, Messrs Blottisre, Paris Cie, Swansea Brook, Mr Butlin, Mr Bhacka, Messrs Brothers, Mr Bryant, J Blumer, C Berkeley, Mr Barrow, Mr Brown, Messrs Bridge, Co Cross, ; Aiken, Mr Copestake, Derby Messrs, Son Cook, London Custance, Messrs Carre, C Naiid, J Carroll, A Cooper, W Calvert, Lon- Don Corlette, J Clarke, T Dutton, ; Dalby, M Drapes, ; Dingwall, Mr Dufton, Mr Edwards, Mrs Evers, C Ewart, London Etbics, W Ewart, Mr Eve, London Eckstein, Buda-Pesth Fairplay, Messrs Fassett, Johnson London
Journal: BMJ (1898)

During tlle past twelve ionths I have used a Christy saddle.Within this time I have had two saddles, a spring having been broken in the first.Like Dr. R. Atkin- son I found my ischial tuberosities somewhat tender after a long ride wlhen using the first saddle, but with the second this is not the case, as tile spr-ings have elasticity, being quite a different pattern There is (ertainly no perineal pressure.I have given the saddle a good test, my distance being lnearly 4,000 miles, much of this over very rough roads.
Death anxiety, psychological distress, and quality of life (QOL) in adolescent and young adult (AYA) cancer patients with hematologic malignancies in early survivorship.
Authors: Fay J. Hlubocky, Lori S. Muffly, Joseline X. Gomez, Kate Breitenbach, David Cella, Jennifer Lynn McNeer, Wendy Stock, Christopher Daugherty
Journal: Journal of Clinical Oncology (2016)

10073 Background: Prior research reveals AYA experience psychological distress living with future uncertainty regarding their cancer. However, coping with death anxiety and its effect on psychological well-being and QOL of AYA hematologic survivors has not been described. Methods: AYA patients (15-40 years at diagnosis) of acute leukemia, aggressive non-Hodgkin lymphoma, and Hodgkin lymphoma undergoing curative intent therapy (on-treatment cohort) or 2 year completion of therapy and in remission (early survivor cohort) completed following measures: depression (CES-D), state anxiety (STAI-S), PTSD (PCL-C), QOL (FACIT-G). Semi-structured interviews evaluated death anxiety: pain-suffering; loneliness, unknown. Results: 62 AYA subjects (26 on-treatment, 36 early survivors) were interviewed. For total population: median age at diagnosis 26y (15-39); 64% male; 59% Ca; 79% college/postgrad educ; 41% income < $75,000yr; 52% and 48% lymphoma or leukemia dx, respectively. Overall, 67% AYA acknowledged death anxiety. Of these, 45% of AYA reported fear of pain-suffering; 26% reported fear of loneliness; 41% reported fear of unknown. AYA with death anxiety had higher STAI-S anxiety (39 ± 9.9 v 30.7 ± 9.7, p = .01) and CES-D depression (23 ± 12.3 v 12.5 ± 8.3, p < .00). Also, AYA with death anxiety had poorer FACT-G QOL (80.5 ± 16 v 86 ± 14.3, p = .04). Fear of suffering was associated with moderate illness-related PTSD symptoms (34 ± 11.3 v 27.5 ± 10.4, p < .00). AYA with fear of loneliness had greater CES-D (19 ± 13.3 v 10.2 ± 9.4, p = .02). On-treatment AYA were more likely to acknowledge death anxiety (52% v 43%, p = .03) than early survivor cohort. Conclusions: AYAs with hematologic malignancies report fears of dying which negatively impacting QOL. Tailored age-specific psychological interventions designed to address survivor fears are needed.
LE cell test and antinuclear antibodies
Authors: E. L. Dubois
Journal: JAMA (1967)

Since Hargraves' description of the LE cell in 1948, our understanding of systemic lupus erythematosus (SLE) has made rapid strides.<sup>1</sup>Extensive investigations into the immunological and clinical implications of this finding have greatly changed our concept of the disease and have shown that it is a relatively common disorder.<sup>2</sup> It is currently believed that LE cell formation is due to an antibody to nucleoprotein.<sup>3</sup>Patients with SLE also have many other antibodies, most important and specific of which may be the one against deoxyribonucleic acid.<sup>4</sup> <h3>Serologic Tests for Systemic Lupus Erythematosus</h3> Antinuclear antibody tests have been extensively studied during the past 12 years. They are useful for the diagnosis of SLE and other autoimmune disorders but their sensitivity and specificity cannot be correlated between laboratories since there are no standard reagents or test sera. Consequently, each laboratory must have its own control studies of the incidence
Reproductive mortality.
Authors: B Jacobson
Journal: BMJ (1979)

Surely the classical process is from the general to the particular, and by going from the particular to the general they have got the process upside down.Either disease is a "unified concept" or it is not a concept at all.To end with I will ask two questions.How do they define the corresponding concept health?Is it possible that we are all, lay and professional alike, pursuing a mirage in our National Health Service ?
THREE PERTINENT QUESTIONS ON MATERNAL FEEDING
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
From the National Institutes of Health
Authors: William Raub
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Medical Education: Variety
Journal: JAMA (1971)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Toxic Shock Syndrome Associated With the Use of the Vaginal Contraceptive Sponge
Authors: M. Andrew Levitt
Journal: JAMA (1985)

<h3>To the Editor.—</h3> Although toxic shock syndrome (TSS) is most commonly associated with the use of vaginal tampons during menstruation,<sup>1</sup>it has been recognized in association with many nonmenstrual conditions. These include surgical incisions, nonsurgical focal infections, the conditions of postpartum mothers, after spontaneous abortion, vaginal infections, pelvic inflammatory disease, and diaphragm use.<sup>2</sup> The Centers for Disease Control has briefly reported on four cases of TSS in association with the use of the vaginal contraceptive sponge and has encouraged reporting of other cases.<sup>1</sup>Currently, 13 confirmed cases of TSS with this association have been reported (K. C. Pearson, oral communication, Center for Drugs and Biologics, Food and Drug Administration, Nov 9, 1984). We report such a case in greater detail. <h3>Report of a Case.—</h3> On the first day of an expected menstrual period, an 18-year-old white, nulligravida woman was seen in the emergency department with a one-day
Characterization of Cadmium Proteinuria in Man and Rat
Authors: Robert R. Lauwerys, Alfred Bernard, Harry A. Roels, Jean-Pierre Buchet, Claude Viau
Journal: Environmental Health Perspectives (1984)

In workers chronically exposed to cadmium and without signs of renal insufficiency, plasma proteins with molecular weight ranging from 11,800 to 450,000 are excreted in greater amount in urine. Increased urinary excretion of low and high molecular weight proteins can occur independently. Because of its greater stability in urine and provided a sensitive immunological technique is used, the determination of retinol-binding protein is a more practical and reliable test of proximal tubular function than beta 2-microglobulin. The evaluation of renal function of workers removed from cadmium exposure indicates that cadmium-induced renal lesions, albeit of slow progression, are not reversible when exposures ceases. In workers chronically exposed to cadmium or removed from cadmium exposure, metallothionein in urine is directly correlated with cadmium in urine but not with cadmium in blood or years of cadmium exposure. The association between cadmium in urine and metallothionein in urine is independent of the status of renal function and the intensity of current exposure to cadmium. Whereas the repeated IP injection of high doses of cadmium to rat gives rise to a mixed or tubular type proteinuria, the prolonged oral administration of cadmium results mainly in the development of a glomerular type proteinuria. The former is usually reversible after cessation of treatment whereas the latter is not. Circulating antiglomerular basement membrane antibodies have been found in man and in rat chronically exposed to cadmium. The pathogenic significance of this finding deserves further investigation.
Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients.
Journal: Journal of Clinical Oncology (1996)

PURPOSE The optimal duration and timing of adjuvant chemotherapy for breast cancer patients remain uncertain and were prospectively studied. PATIENTS AND METHODS We randomly assigned 1,554 premenopausal breast cancer patients with node-positive disease in a 2 x 2 factorial design to receive the following: (A) cyclophosphamide, methotrexate, and fluorouracil for 6 consecutive courses on months 1 to 6 (CMF x 6); (B) CMFx6 plus three single courses of reintroduction CMF given on months 9, 12, and 15; (C) CMF for three consecutive courses on months 1 to 3 (CMFx3); or (D) CMFx3 plus three single courses of reintroduction CMF given on months 6, 9, and 12. Accrual was between July 1986 and April 1993. A total of 1,475 patients (95%) were eligible and assessable. The median follow-up duration was 60 months. RESULTS Patients who received CMFx3 without reintroduction had a 5-year disease-free survival (DFS) rate of 53% compared with 58% for the other three treatment groups (hazards ratio [HR], 1.20; 95% confidence interval [CI], 1.00 to 1.45; P = .04). The increased risk of relapse with CMFx3 was more marked for women aged less than 40 years (308 patients; HR, 1.32; 95% CI, 0.94 to 1.84; P = .11) and for patients with estrogen receptor (ER)-negative tumors (455 patients; HR, 1.45; 95% CI, 1.06 to 2.00; P = .02). Reintroduction chemotherapy provided additional benefit (HR, 0.86; 95% CI, 0.73 to 1.01; p = .07), especially for women &gt; or = 40 years of age (1,167 patients; HR, 0.82; 95% CI, 0.68 to 0.99; P = .04). CONCLUSION Three courses of adjuvant CMF chemotherapy are not sufficient compared with longer duration CMF chemotherapy, especially in younger women and in patients with ER-negative primary tumors. Reintroduction chemotherapy showed some evidence of additional benefit, but remains investigational.
Patients With Nonvalvular Atrial Fibrillation at Low Risk of Stroke During Treatment With Aspirin: Stroke Prevention in Atrial Fibrillation III Study
Authors: None The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators
Journal: JAMA (1998)

Context.—Nonvalvular atrial fibrillation (AF) carries an increased risk for stroke, but absolute rates of stroke vary widely within the broad spectrum of AF patients.Objective.—To prospectively validate a risk stratification scheme identifying patients with AF with low rates of stroke when given aspirin.Design.—Prospective cohort study with mean duration of follow-up of 2.0 years, conducted between 1993 and 1997.Setting.—Outpatient clinics affiliated with academic medical centers.Patients.—Patients with AF categorized as "low risk" based on the absence of 4 prespecified thromboembolic risk factors: recent congestive heart failure or left ventricular fractional shortening of 25% or less, previous thromboembolism, systolic blood pressure greater than 160 mm Hg, or female sex at age older than 75 years.Intervention.—All participants given aspirin, 325 mg/d.Main Outcome Measures.—Ischemic stroke (considered disabling when Rankin score was II or worse 1-3 months later) and systemic embolism (primary events).Results.—Among 892 participants, the mean (SD) age was 67 (10) years, 78% were men, and histories of hypertension, diabetes, and ischemic heart disease were present in 46%, 13%, and 16%, respectively. The rate of primary events was 2.2% per year (95% confidence interval [CI], 1.6%-3.0%), of ischemic stroke was 2.0% per year (95% CI, 1.5%-2.8%), and of disabling ischemic strokes was 0.8% per year (95% CI, 0.5%-1.3%). Those with a history of hypertension had a higher rate of primary events (3.6% per year) than those with no history of hypertension (1.1% per year) (P<.001). The rate of disabling ischemic stroke was low in those with and without a history of hypertension (1.4% per year and 0.5% per year, respectively). The rate of major bleeding during aspirin therapy was 0.5% per year.Conclusion.—Patients with AF who have relatively low rates of ischemic stroke, particularly disabling stroke, during treatment with aspirin can be reliably identified.
INTELLIGENT COWS.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Cincinnati College of Medicine and Surgery.-
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Correction
Journal: BMJ (1947)

BRITISHthe condition.There is no connexion whatever between tissue sensitivity and the susceptibility of micro-organisms to peni- cillin; hence there is no danger that desensitization would lead to any impairment of therapeutic effect. PediculosisQ.-Are there other hosts than mtiant for Pediculus capitis anld corporis and Phthirius pubis?If so, what?A.-There are no other natural hosts than man.Some American workers have shown that P. humanus corporis can be
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel Blockers vs Angiotensin-Converting Enzyme Inhibitors
Authors: J. L. Houghton
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic
Authors: P. A. Patriarca
Journal: JAMA (1985)

From December 10, 1982, to March 4, 1983, when influenza A (H3N2) viruses circulated in Michigan, outbreaks of influenza-like illness were identified in seven nursing homes in Genesee County; 272 (27%) of 1,018 residents were affected. Unvaccinated residents were more likely than vaccinated residents to become ill (risk ratio [RR], 2.6; 95% confidence interval [CI], 1.8-3.6) and were subsequently more likely to be hospitalized (RR, 2.4; 95% CI, 1.2-4.8), develop roentgenographically proven pneumonia (RR, 2.9; 95% CI, 1.6-5.3), or die (RR, 5.6; 95% CI, 1.2-9.1). Similar observations were made during investigations in six of the eight remaining nursing homes in Genesee County, in which 57 (12%) of 458 residents became ill sporadically. These findings suggest that influenza vaccine can reduce the incidence and severity of influenza virus infections among the elderly and chronically ill and underscore the importance of vaccination programs for those in nursing homes and in the general community. (<i>JAMA</i>1985;253:1136-1139)
Editorial
Authors: Jose C. Principe
Journal: IEEE Reviews in Biomedical Engineering (2010)

This is the third volume of the IEEE Reviews in Biomedical Engineering (IEEE RBME), and I hope it will keep the success of the previous volumes. Although the journal is still too young for me to bet on its future, I am convinced that the journal’s format and the quality of the articles will draw an ever increasing number of young and more seasoned researchers, who are in need of a comprehensive and authoritative introduction to the continuously unfolding stream of new biomedical research topics. This year IEEE RBME journal was successfully reviewed by the IEEE Technical Activities Board (TAB), and the EMB Society is seeking its inclusion in PubMED as soon as possible. The author was reappointed for a second term as EiC and his goal will continue to be, with the help of authors, Editorial and Area Editor Boards, the driver for the society directives that created the journal. He states he will settle for no less than to promote IEEE RBME as the premier review journal in Biomedical Engineering.
Effects of 'passive smoking' lead nonsmokers to step up campaign
Authors: C. Marwick
Journal: JAMA (1985)

In 1971, when he was surgeon general of the Public Health Service, Jesse L. Steinfeld, MD, pointed to the risks of involuntary smoking. Breathing someone else's tobacco smoke is just as bad for the health as inhaling it directly, Steinfeld said. At the time, his remarks—which he made before the Interagency Council on Smoking and Health—got little, indeed virtually no, public attention. But they were the first to be made by a public health official on a topic that has now moved to center stage in the smoking and health issue. Most of the evidence that prompted Steinfeld's remarks was based on animal data. Since then, a substantial amount of work has been published— more than 100 papers—on the effects of passive smoking in humans. In a current article (<i>J Environ Int</i>, in press), James L. Repace, MS, a physicist at the Environmental Protection Agency, and Alfred H. Lowrey, PhD,